PTK2 and hepatocellular carcinoma: Furthermore, Gnani et al. reported the concomitant upregulation of FAK, EZH2, and H3K27me3 in hepatocellular carcinoma tissue arrays, which was correlated with disease severity, as determined by tumor staging, differentiation, and metastasis [31].